Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1. This appears to be a minor version update with no impact on the study details or user interactions.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the page header; this is a UI update with no impact on study content or user interactions.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a glossary display option and updated small text labels (capitalization of QC criteria and FEAR Act data) with the revision bumped to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision v3.3.4 was added and v3.3.3 was removed. This appears to be a minor administrative update to the site versioning and does not change study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.